drugset / Trial / NCT00703833

A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)

NCT00703833 ↗

Phase 2 Completed 51 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder.

Timeline

Start
2002-09
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0777 Small molecule 3 mg —
Subject MK0777 Small molecule 6 mg —
Subject MK0777 Small molecule 9 mg —